MAMMALIAN PHENOTYPE - ANNOTATIONS
The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.
Term: neoplasm
Accession: MP:0002006
browse the term
Definition: the observable morphological and physiological characteristics of a benign or malignant tissue growth resulting from uncontrolled cell proliferation in a mammalian organism that are manifested through development and lifespan
Synonyms: narrow_synonym: tumorigenesis; tumourigenesis
xref: HP:0002664
G
Cdk4
cyclin-dependent kinase 4
IDA
RGD
PMID:12070150
RGD:625485
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
IMP
RGD
PMID:9854145
RGD:5132885
NCBI chr10:79,394,999...79,400,418
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
G
Serpine1
serpin family E member 1
IMP
RGD
PMID:18460465
RGD:2306009
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Apc
APC regulator of WNT signaling pathway
IMP
compared to treated females, mock treated males
RGD
PMID:17360473
RGD:1601201
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
ApcPirc
APC, WNT signaling pathway regulator; polyposis in the rat colon
IMP
compared to treated females, mock treated males
RGD
PMID:17360473
RGD:1601201
G
Rag2
recombination activating 2
induced
IMP
XCO:0000709
RGD
PMID:30206106
RGD:38508903
NCBI chr 3:108,357,399...108,367,186
Ensembl chr 3:87,902,238...87,911,066
G
Apc
APC regulator of WNT signaling pathway
sexual_dimorphism
IMP
compared to treated females
RGD
PMID:17360473
RGD:1601201
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
ApcPirc
APC, WNT signaling pathway regulator; polyposis in the rat colon
sexual_dimorphism
IMP
compared to treated females
RGD
PMID:17360473
RGD:1601201
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
IAGP
DNA:deletion
RGD
PMID:20065947
RGD:7248760
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
IAGP
DNA:deletion
RGD
PMID:20065947
RGD:7248760
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:104,010,680...104,019,050
G
Erbb2
erb-b2 receptor tyrosine kinase 2
IDA
RGD
PMID:1359541
RGD:1582128
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
IAGP
DNA:deletion
RGD
PMID:19825367
RGD:5147850
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:12,312,160...12,314,897
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
IAGP
RGD
PMID:12036912
RGD:619590
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1bwe
cyclin-dependent kinase inhibitor 1B; white eye mutation
IAGP
RGD
PMID:12036912
RGD:619590
G
Brca2
BRCA2, DNA repair associated
IMP
RGD
PMID:16964288
RGD:1599505
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:59,819...100,567
G
Brca2m1Uwm
BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison
IMP
RGD
PMID:16964288
RGD:1599505
G
Msh6
mutS homolog 6
IMP
RGD
PMID:18417481
RGD:2292505
NCBI chr 6:12,316,190...12,333,505
Ensembl chr 6:6,562,632...6,579,956
G
Msh6m1Hubr
mutS homolog 6; ENU induced mutant 1, Hubr
IMP
RGD
PMID:18417481
RGD:2292505
G
Tp53
tumor protein p53
IMP
RGD
PMID:22917926
RGD:11075077
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tp53em1Sage
tumor protein p53; ZFN induced mutant 1, Sage
IMP
RGD
PMID:22917926
RGD:11075077
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all